| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB0419176AGB0419176D0 (en) | 2004-08-27 | 2004-08-27 | Method of treatment and compositions | 
| MX2007002169AMX2007002169A (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases. | 
| PCT/GB2005/003350WO2006021803A2 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases | 
| ES05775408TES2403558T3 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases | 
| JP2007528987AJP5117189B2 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases | 
| EP05775408AEP1799230B1 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases | 
| CA002576159ACA2576159A1 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases | 
| US11/660,249US20080125404A1 (en) | 2004-08-27 | 2005-08-25 | Purine and Pyrimidine Cdk Inhitbitors and Their use for The Treatment of Autoimmune Diseases | 
| CN2005800370898ACN101048160B (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use in the preparation of medicaments for treating autoimmune diseases | 
| PL05775408TPL1799230T3 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases | 
| AU2005276231AAU2005276231A1 (en) | 2004-08-27 | 2005-08-25 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases | 
| US13/464,362US8809350B2 (en) | 2004-08-27 | 2012-05-04 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases | 
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB0419176AGB0419176D0 (en) | 2004-08-27 | 2004-08-27 | Method of treatment and compositions | 
| Publication Number | Publication Date | 
|---|---|
| GB0419176D0true GB0419176D0 (en) | 2004-09-29 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GB0419176ACeasedGB0419176D0 (en) | 2004-08-27 | 2004-08-27 | Method of treatment and compositions | 
| Country | Link | 
|---|---|
| GB (1) | GB0419176D0 (en) | 
| Publication | Publication Date | Title | 
|---|---|---|
| SI1791791T1 (en) | Methods and compositions for treatment of water | |
| GB2423928B (en) | Methods and compositions for treating pain | |
| GB2414666B (en) | Sanitizing composition and method of preparation | |
| IL178996A0 (en) | Thienopyridinone compounds and methods of treatment | |
| EP1737482A4 (en) | Compositions and methods for treating diseases | |
| ZA200704677B (en) | Compositions and methods for the treatment of autism | |
| IL181896A0 (en) | Methods and compositions for the treatment of hyperlipidemia | |
| IL179931A0 (en) | Compositions and methods for treatment of cardiovascular disease | |
| IL182436A0 (en) | Thienopyridinone compounds and methods of treatment | |
| IL174627A0 (en) | Compositions and methods for treatment of burns | |
| EP1696910A4 (en) | Compositions and methods for treatment of fibrosis | |
| IL180195A0 (en) | Aequorin-containing compositions and methods of using same | |
| IL187405A0 (en) | Methods and compositions for the treatment of pain | |
| EP1786265A4 (en) | Novel compositions and methods of treatment | |
| ZA200709024B (en) | Method of well treatment and construction | |
| ZA200703087B (en) | Methods and compositions for the treatment of hyperlipidemia | |
| GB0324523D0 (en) | Compositions and methods of treatment | |
| EP1824462A4 (en) | Composition and method for the treatment of tauopathies | |
| GB0426196D0 (en) | Methods of treatment | |
| PL1812797T3 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
| EP1784193A4 (en) | Composition and method for treatment and prevention of atherosclerosis | |
| GB0520930D0 (en) | Composition and method of use | |
| GB0419175D0 (en) | Method of treatment and compositions | |
| GB0504657D0 (en) | Compositions and methods of treatment | |
| ZA200710476B (en) | Methods and compositions for the treatment of pain | 
| Date | Code | Title | Description | 
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |